Apellis Pharma has become the first company to claim FDA approval for a drug to treat geographic atrophy (GA), a sight ... by the loss of photoreceptors and retinal pigment epithelial (RPE ...

dry AMD progresses into geographic atrophy (GA), characterized by atrophy of the retinal pigment epithelium (RPE), photoreceptors, and choriocapillaris, responsible for a progressive vision loss.

Alkeus Pharmaceuticals, Inc, a biopharma company dedicated to preserving the sight of individuals impacted by retinal diseases, announced that patients with geographic atrophy secondary to age-related ...

Serpiginous chorioretinopathy is a rare form of posterior uveitis that causes inflammation and subsequent atrophy of the choroid, RPE and retina. The disease typically starts near the optic nerve ...

Tenpoint Therapeutics, Limited ("Tenpoint") and Visus Therapeutics, Inc., ("Visus") announce today the completion of their ...